Contributor
Scientists have uncovered a previously unknown mechanism that helps explain why pancreatic cancer remains one of medicine's most formidable foes.
Apr 15, 2025
A Phase 1/2 clinical trial reveals that AEF0217, a new molecule targeting brain receptor activity, safely improves communication and daily living skills in adults with Down syndrome.
Dec 17, 2024
A new study reveals that consuming the right amount of calories at breakfast - about a quarter of your daily intake - could be key to reducing cardiovascular disease risk.
Dec 11, 2024
